179
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Abstract submission is now open for RExPO25, the 4th International Conference on Systems Medicine, AI & Drug Repurposing.  Submit your proposal for a talk or poster and join us in Barcelona, Spain, September 24-26, 2025. 

      Deadline for abstracts is June 30, 2025

      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A regulatory roadmap for repurposing: comparing pathways for making repurposed drugs available in the EU, UK, and US

      Preprint
      In review
      research-article
      Bookmark

            Abstract

            Content

            Author and article information

            Journal
            DrugRxiv
            REPO4EU
            18 November 2024
            Affiliations
            [1 ] departments of IQ health radiology at Radboudumc, Nijmegen, the Netherlands ( https://ror.org/05wg1m734)
            [2 ] department of Clinical Epidemiology & Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands ( https://ror.org/02d9ce178)
            [3 ] Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands ( https://ror.org/02jz4aj89)
            [4 ] Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA ( https://ror.org/04b6nzv94)
            [5 ] 3D-PharmXchange, Tilburg, The Netherlands;
            [6 ] Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. ( https://ror.org/04b6nzv94)
            Author notes
            Author information
            https://orcid.org/0000-0003-3102-6011
            Article
            10.58647/DRUGARXIV.PR000018.v1
            6099ceed-48db-443f-b12a-df72c9ffb693

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            : 18 November 2024
            Funding
            Funded by: funder-id http://dx.doi.org/10.13039/100018696, HORIZON EUROPE Health;
            Award ID: 101057619
            Categories

            All data generated or analysed during this study are included in this published article (and its supplementary information files).
            Law
            Drug repurposing,prescription drug regulation,European Medicines Agency,US Food and Drug Administration,UK Medicines and Healthcare products Regulatory Agency,drug approvals

            Comments

            Comment on this article